Glenmark Pharmaceuticals Limited (BOM:532296)

Glenmark Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 17, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	462,584	434,866	270,463	131,124	124,718	131,124
Market Cap Growth	60.79%	60.79%	106.27%	5.14%	-4.88%	125.75%
Enterprise Value	470,254	434,470	315,126	164,781	152,778	150,427
Last Close Price	1639.85	1540.05	954.77	462.32	436.82	456.74
PE Ratio	44.18	41.53	-	44.11	13.24	13.52
PS Ratio	3.44	3.24	2.14	1.13	1.01	1.20
PB Ratio	5.23	4.91	3.45	1.33	1.32	1.86
P/TBV Ratio	6.26	5.89	4.15	1.86	1.83	2.77
P/FCF Ratio	-	-	-	743.80	39.15	36.78
P/OCF Ratio	-	-	-	20.97	11.25	11.59
EV/Sales Ratio	3.50	3.23	2.49	1.41	1.24	1.38
EV/EBITDA Ratio	19.08	17.63	17.22	11.53	7.99	7.74
EV/EBIT Ratio	23.76	21.95	21.80	14.48	8.30	8.77
EV/FCF Ratio	-29.82	-	-	934.71	47.96	42.20
Debt / Equity Ratio	0.28	0.28	0.16	0.47	0.42	0.71
Debt / EBITDA Ratio	1.00	1.00	0.64	3.03	1.98	2.45
Debt / FCF Ratio	-	-	-	261.38	12.44	13.99
Asset Turnover	0.88	0.88	0.75	0.64	0.75	0.72
Inventory Turnover	1.57	1.57	1.87	1.81	1.90	1.74
Quick Ratio	0.85	0.85	0.75	1.06	1.08	1.00
Current Ratio	1.56	1.56	1.28	2.10	1.77	1.75
Return on Equity (ROE)	12.54%	12.54%	-20.70%	-0.93%	12.04%	14.77%
Return on Assets (ROA)	8.14%	8.14%	5.36%	3.90%	7.04%	7.08%
Return on Capital (ROIC)	12.13%	12.13%	7.68%	5.11%	9.04%	9.20%
Return on Capital Employed (ROCE)	19.60%	19.60%	16.90%	8.00%	14.80%	15.00%
Earnings Yield	2.26%	2.41%	-5.55%	2.27%	7.55%	7.40%
FCF Yield	-3.41%	-3.63%	-4.30%	0.13%	2.55%	2.72%
Dividend Yield	0.15%	0.16%	0.26%	0.54%	0.57%	0.55%
Payout Ratio	6.73%	6.73%	-	23.68%	9.84%	7.26%
Buyback Yield / Dilution	-0.02%	-0.02%	-0.00%	-	-	-
Total Shareholder Return	0.13%	0.14%	0.26%	0.54%	0.57%	0.55%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.